Retinol-binding protein, transthyretin, and C-reactive protein in extremely low birth weight (ELBW) infants

Journal of Perinatology

Volumn 25, Issue 11, 2005, Pages 714-719

  Ambalavanan, Namasivayam ^a   Ross, A Catharine ^b   Carlo, Waldemar A ^a  

^a University of Alabama at Birmingham   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; PREALBUMIN; RETINOL; RETINOL BINDING PROTEIN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFLAMMATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DEATH; PREDICTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETINOL DEFICIENCY; VITAMIN BLOOD LEVEL;

AREA UNDER CURVE; BRONCHOPULMONARY DYSPLASIA; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INFLAMMATION; MALE; PREALBUMIN; RETINOL-BINDING PROTEINS; ROC CURVE; VITAMIN A DEFICIENCY;

EID: 27844432269     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211398     Document Type: Article

References (26)

1. Shenai JP, Chytil F, Jhaveri A, Stahlman MT. Plasma vitamin A and retinol-binding protein in premature and term neonates. J Pediatr 1981;99:302-5.
2. Shenai JP, Chytil F, Stahlman MT. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res 1985;19:185-8.
3. Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987;111:269-77.
4. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999;340:1962-8.
5. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev 2002; (4):CD 000501.
6. Ambalavanan N, Wu TJ, Tyson JE, Kennedy KA, Roane C, Carlo WA. A comparison of three vitamin A dosing regimens in extremely premature infants. J Pediatr 2003;142:656-61.
7. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53:81-94.
8. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553-62.
9. Rosales FJ, Ritter SJ, Zolfaghari R, Smith JE, Ross AC. Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A sufficient rats. J Lipid Res 1996;37:962-71.
10. Navab M, Smith JE, Goodman DS. Rat plasma prealbumin. Metabolic studies on effects of vitamin A status and on tissue distribution. J Biol Chem 1977;252:5107-14.
11. Rosales FJ, Ross AC. A low molar ratio of retinol binding protein to transthyretin indicates vitamin A deficiency during inflammation: studies in rats and a posterior analysis of vitamin A-supplemented children with measles. J Nutr 1998;128:1681-7.
12. Speer C, Bruns A, Gahr M. Sequential determination of CRP, alpha 1-antitrypsin and haptoglobin in neonatal septicaemia. Acta Paediatr Scand 1983;72:679-83.
13. Wagle S, Grauaug A, Kohan R, Evans SF. C-reactive protein as a diagnostic tool of sepsis in very immature babies. J Paediatr Child Health 1994;30:40-4.
14. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998; 102:E41.
15. Yeh ET. CRP as a mediator of disease. Circulation 2004;109II:11-4.
16. Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
17. Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001;103:2531-4.
18. Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123:2043-9.
19. Lockitch G, Halstead AC, Quigley G, MacCallum C. Age- and sex-specific pediatric reference intervals: Study design and methods illustrated by measurement of serum proteins with the Behring LN Nephelometer. Clin Chem 1988;34:1618-21.
20. Zago LB, Dupraz H, Sarchi MI, Rio ME. The molar ratio of retinol-binding protein to transthyretin in the assessment of vitamin A status in adults. Proposal of a cut-off point. Clin Chem Lab Med 2002;40:1301-7.
21. Rosales FJ, Chau KK, Haskell MH, Shankar AH. Determination of a cut-off value for the molar ratio of retinol-binding protein to transthyretin (RBP:TTR) in Bangladeshi patients with low hepatic vitamin A stores. J Nutr 2002;132:3687-92.
22. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 2004;45:1169-96.
23. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983;34:141-212.
24. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-7.
25. Backes JM, Howard PA, Moriarty PM. Role of C-reactive protein in cardiovascular disease. Ann Pharmacother 2004;38:110-8.
26. Teragawa H, Fukuda Y, Matsuda K, et al. Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart 2004;90:750-4.